{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:54:09Z","timestamp":1768830849955,"version":"3.49.0"},"reference-count":223,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Cancer has been widely investigated yet limited in its manifestation. Cancer treatment holds innovative and futuristic strategies considering high disease heterogeneity. Chemotherapy, radiotherapy and surgery are the most explored pillars; however optimal therapeutic window and patient compliance recruit constraints. Recently evolved immunotherapy demonstrates a vital role of the host immune system to prevent metastasis recurrence, still undesirable clinical response and autoimmune adverse effects remain unresolved. Overcoming these challenges, tunable biomaterials could effectively control the co-delivery of anticancer drugs and immunomodulators. Current status demands a potentially new approach for minimally invasive, synergistic, and combinatorial nano-biomaterial assisted targeted immune-based treatment including therapeutics, diagnosis and imaging. This review discusses the latest findings of engineering biomaterial with immunomodulating properties and implementing novel developments in designing versatile nanosystems for cancer theranostics. We explore the functionalization of nanoparticle for delivering antitumor therapeutic and diagnostic agents promoting immune response. Through understanding the efficacy of delivery system, we have enlightened the applicability of nanomaterials as immunomodulatory nanomedicine further advancing to preclinical and clinical trials. Future and present ongoing improvements in engineering biomaterial could result in generating better insight to deal with cancer through easily accessible immunological interventions.<\/jats:p>","DOI":"10.3389\/fchem.2020.631351","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:30:02Z","timestamp":1611894602000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics"],"prefix":"10.3389","volume":"8","author":[{"given":"Amreen","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suditi","family":"Neekhra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barkha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jin2.63","article-title":"Functional recovery of natural killer cell activity by nanoparticle\u2010mediated delivery of transforming growth factor beta 2 small interfering RNA","volume":"4","author":"Adjei","year":"2019","journal-title":"J. Interdiscip. Nanomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17247","DOI":"10.1073\/pnas.1305000110","article-title":"Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms","volume":"110","author":"Agarwal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nano.2013.09.011","article-title":"Gold nanoparticle mediated cancer immunotherapy","volume":"10","author":"Almeida","year":"2014","journal-title":"Nanomedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"083904","DOI":"10.1063\/1.4942618","article-title":"Superparamagnetic nanoparticles encapsulated in lipid vesicles for advanced magnetic hyperthermia and biodetection","volume":"119","author":"Alonso","year":"2016","journal-title":"J. Appl. Phys."},{"key":"B6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tibtech.2020.06.003","article-title":"Extracellular matrix mimics usinghyaluronan-based biomaterials","volume":"39","author":"Amorim","year":"2020","journal-title":"Trends Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ddr.430270103","article-title":"Interleukin\u20102 in liposomes: increased intravenous potency and less pulmonary toxicity in the rat","volume":"27","author":"Anderson","year":"1992","journal-title":"Drug Dev. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"eaba8564","DOI":"10.1126\/sciadv.aba8564","article-title":"Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy","volume":"6","author":"Au","year":"2020","journal-title":"Sci. Adv."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-824X-3-3","article-title":"Nanotechnology-mediated targeting of tumor angiogenesis","volume":"3","author":"Banerjee","year":"2011","journal-title":"Vasc. Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01443615.2018.1493441","article-title":"New prophylactics human papilloma virus (HPV) vaccines against cervical cancer","volume":"39","author":"Barra","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jcyt.2017.07.008","article-title":"Phase 1 clinical trial of adoptive immunotherapy using \"off-the-shelf\" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia","volume":"19","author":"Boyiadzis","year":"2017","journal-title":"Cytotherapy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbcan.2014.01.004","article-title":"Tumor-induced perturbations of cytokines and immune cell networks","volume":"1845","author":"Burkholder","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1701439","DOI":"10.1002\/adhm.201701439","article-title":"Photothermally controlled MHC class I restricted CD8+ T-cell responses elicited by hyaluronic acid decorated gold nanoparticles as a vaccine for cancer immunotherapy","volume":"7","author":"Cao","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"B18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.apsb.2018.12.009","article-title":"Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma","volume":"9","author":"Cao","year":"2019","journal-title":"Acta Pharm. Sin. B."},{"key":"B19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fonc.2013.00259","article-title":"Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents","volume":"3","author":"Cesca","year":"2013","journal-title":"Front Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1021\/acs.nanolett.9b00579","article-title":"Iron nanoparticles for low-power local magnetic hyperthermia in combination with immune checkpoint blockade for systemic antitumor therapy","volume":"19","author":"Chao","year":"2019","journal-title":"Nano Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1039\/c7tb00944e","article-title":"Encapsulation of Au\/Fe3O4 nanoparticles into a polymer nanoarchitecture with combined near infrared-triggered chemo-photothermal therapy based on intracellular secondary protein understanding","volume":"5","author":"Chen","year":"2017","journal-title":"J. Mater. Chem. B."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/natrevmats.2017.24","article-title":"Rethinking cancer nanotheranostics","volume":"2","author":"Chen","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/OTT.S97828","article-title":"A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer","volume":"9","author":"Chen","year":"2016","journal-title":"OncoTargets Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1802134","DOI":"10.1002\/advs.201802134","article-title":"Tumor microenvironment-triggered aggregated magnetic nanoparticles for reinforced image-guided immunogenic chemotherapy","volume":"6","author":"Chen","year":"2019","journal-title":"Adv. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.actbio.2019.12.012","article-title":"Antibody-directed metal-organic framework nanoparticles for targeted drug delivery","volume":"103","author":"Cherkasov","year":"2020","journal-title":"Acta Biomater."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1039\/c9nr10674j","article-title":"Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy","volume":"12","author":"Chi","year":"2020","journal-title":"Nanoscale"},{"key":"B29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fcell.2020.00402","article-title":"Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy","volume":"8","author":"Chulpanova","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00262-014-1566-3","article-title":"Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer","volume":"63","author":"Chung","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1002\/adfm.201501283","article-title":"Dual targeted immunotherapy via","volume":"25","author":"Conde","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.4049\/jimmunol.0802113","article-title":"Chitin is a size-dependent regulator of macrophage TNF and IL-10 production","volume":"182","author":"Da Silva","year":"2009","journal-title":"J. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2018.09.026","article-title":"The application of nanotechnology in immune checkpoint blockade for cancer treatment","volume":"290","author":"Deng","year":"2018","journal-title":"J. Contr. Release"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41467-019-09221-x","article-title":"Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors","volume":"10","author":"Duan","year":"2019","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/toxsci\/kfm217","article-title":"Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials","volume":"100","author":"Dutta","year":"2007","journal-title":"Toxicol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2967\/jnumed.116.177493","article-title":"Molecular imaging of immunotherapy targets in cancer","volume":"57","author":"Ehlerding","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/acs.molpharmaceut.8b01157","article-title":"Doxorubicin and anti-PD-L1 antibody conjugated gold nanoparticles for colorectal cancer photochemotherapy","volume":"16","author":"Emami","year":"2019","journal-title":"Mol. Pharm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1158\/1078-0432.CCR-16-0600","article-title":"Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: A phase I clinical trial","volume":"23","author":"Exley","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1021\/acs.chemrev.7b00258","article-title":"Nanotechnology for multimodal synergistic cancer therapy","volume":"117","author":"Fan","year":"2017","journal-title":"Chem. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1039\/b902182e","article-title":"Multifunctional magnetic nanoparticles for medical imaging applications","volume":"19","author":"Fang","year":"2009","journal-title":"J. Mater. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/acsmaterialslett.0c00078","article-title":"Different strategies for organic nanoparticle preparation in biomedicine","volume":"2","author":"Fang","year":"2020","journal-title":"ACS Materials Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"B44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1146\/annurev-chembioeng-080615-034446","article-title":"Nanoparticle-based modulation of the immune system","volume":"7","author":"Fang","year":"2016","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"B45","volume-title":"Biochemistry, lipopolysaccharide","author":"Farhana","year":"2020"},{"key":"B46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","article-title":"Minimum information reporting in bio\u2013nano experimental literature","volume":"13","author":"Faria","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tibtech.2009.12.007","article-title":"Frontiers in cancer nanomedicine: directing mass transport through biological barriers","volume":"28","author":"Ferrari","year":"2010","journal-title":"Trends Biotechnol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"13232","DOI":"10.1002\/anie.201900594","article-title":"Radionuclide\u2010activated nanomaterials and their biomedical applications","volume":"58","author":"Ferreira","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"B49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00262-018-2207-z","article-title":"Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma","volume":"67","author":"Gargett","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1021\/cr500304f","article-title":"Broad family of carbon nanoallotropes: classification, chemistry, and applications of fullerenes, carbon dots, nanotubes, graphene, nanodiamonds, and combined superstructures","volume":"115","author":"Georgakilas","year":"2015","journal-title":"Chem. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.csbj.2019.03.015","article-title":"The discovery of biomarkers in cancer immunotherapy","volume":"17","author":"George","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B54","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.cobme.2020.100255","article-title":"Future of additive manufacturing in healthcare","volume":"17","author":"Ghomi","year":"2020","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"B55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cell.2015.03.037","article-title":"Immunoengineering: how nanotechnology can enhance cancer immunotherapy","volume":"161","author":"Goldberg","year":"2015","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/GAD.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/bc049951i","article-title":"Toxicity of gold nanoparticles functionalized with cationic and anionic side chains","volume":"15","author":"Goodman","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"107456","DOI":"10.1016\/j.pharmthera.2019.107456","article-title":"Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: recent progress and challenges in treatment and tracking response to immunotherapy","volume":"207","author":"Gorbet","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"25777","DOI":"10.1021\/acsami.6b08663","article-title":"Sub-micrometer magnetic nanocomposites: insights into the effect of magnetic nanoparticles interactions on the optimization of SAR and MRI performance","volume":"8","author":"Grillo","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biomaterials.2018.04.039","article-title":"Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase","volume":"171","author":"Guan","year":"2018","journal-title":"Biomaterials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1021\/nn5002112","article-title":"Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles","volume":"8","author":"Guo","year":"2014","journal-title":"ACS Nano"},{"key":"B62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1479-5876-9-204","article-title":"A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma","volume":"9","author":"Hamid","year":"2011","journal-title":"J. Transl. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00109-014-1143-4","article-title":"Human hepatocellular carcinoma-infiltrating CD4+CD69 +Foxp3- regulatory T cell suppresses T cell response via membrane-bound TGF-\u03b21","volume":"92","author":"Han","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/OTT.S48883","article-title":"Extracellular matrix as target for antitumor therapy","volume":"8","author":"Harisi","year":"2015","journal-title":"OncoTargets Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02376-y","article-title":"Antifibrotic therapy to normalize the tumor microenvironment","volume":"18","author":"Hauge","year":"2020","journal-title":"J. Transl. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA-and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"key":"B68","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","article-title":"Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity","volume":"65","author":"Hirano","year":"2005","journal-title":"Canc. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review","volume":"15","author":"Hossen","year":"2019","journal-title":"J. Adv. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1800236","DOI":"10.1002\/smll.201800236","article-title":"Immobilization of photo-immunoconjugates on nanoparticles leads to enhanced light-activated biological effects","volume":"14","author":"Huang","year":"2018","journal-title":"Small"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41427-018-0091-9","article-title":"Bioinspired tumor-homing nanosystem for precise cancer therapy via reprogramming of tumor-associated macrophages","volume":"10","author":"Huang","year":"2018","journal-title":"NPG Asia Mater."},{"key":"B73","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2217\/17435889.2.5.681","article-title":"Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy","volume":"2","author":"Huang","year":"2007","journal-title":"Nanomedicine"},{"key":"B74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nnano.2015.25","article-title":"In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging","volume":"10","author":"Huynh","year":"2015","journal-title":"Nat. Nanotechnol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1567201811666140822112516","article-title":"Nanomedicines based drug delivery systems for anti-cancer targeting and treatment","volume":"12","author":"Jain","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"B77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41551-017-0029","article-title":"Designing nanomedicine for immuno-oncology","volume":"1","author":"Jiang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/bjc.2013.645","article-title":"Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients","volume":"109","author":"Jie","year":"2013","journal-title":"Br. J. Canc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1021\/acs.bioconjchem.5b00551","article-title":"Hyaluronic acid modified tantalum oxide nanoparticles conjugating doxorubicin for targeted cancer theranostics","volume":"26","author":"Jin","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/ijc.27535","article-title":"Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25-FOXP3- T cells","volume":"131","author":"Kakita","year":"2012","journal-title":"Int. J. Canc."},{"key":"B81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/85286","article-title":"Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex","volume":"2","author":"Kalergis","year":"2001","journal-title":"Nat. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1021\/nl301206p","article-title":"Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix","volume":"12","author":"Kanapathipillai","year":"2012","journal-title":"Nano Lett."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.7150\/thno.34415","article-title":"Current and future imaging methods for evaluating response to immunotherapy in neuro-oncology","volume":"9","author":"Kasten","year":"2019","journal-title":"Theranostics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jnt1010001","article-title":"Nanotheranostic, next generation prerequisite for better health","volume":"1","author":"Kaushik","year":"2018","journal-title":"J. Nanotheranostics."},{"key":"B86","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2014.12.018","article-title":"Improving drug delivery to solid tumors: priming the tumor microenvironment","volume":"201","author":"Khawar","year":"2014","journal-title":"J. Contr. Release"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1700012","DOI":"10.1002\/adhm.201700012","article-title":"Dendritic mesoporous silica nanoparticles for pH-stimuli- responsive drug delivery of TNF-alpha","volume":"6","author":"Kienzle","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"B89","doi-asserted-by":"publisher","first-page":"H217","DOI":"10.1002\/adma.201102313","article-title":"Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers","volume":"23","author":"Kievit","year":"2011","journal-title":"Adv. Mater."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/electronics9071105","article-title":"Intercellular bioimaging and biodistribution of gold nanoparticle-loaded macrophages for targeted drug delivery","volume":"9","author":"Kim","year":"2020","journal-title":"Electronics (Switzerland)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer","volume":"25","author":"Klemm","year":"2014","journal-title":"Trends Cell Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1021\/nn402145t","article-title":"Dysregulation of macrophage activation profiles by engineered nanoparticles","volume":"7","author":"Kodali","year":"2013","journal-title":"ACS Nano"},{"key":"B93","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.humpath.2007.07.003","article-title":"Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas","volume":"39","author":"Kondratiev","year":"2008","journal-title":"Hum. Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/JTO.0000000000000364","article-title":"Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760)","volume":"10","author":"Kurose","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11010068","article-title":"Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency","volume":"11","author":"Kutova","year":"2019","journal-title":"Cancers"},{"key":"B97","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-physchem-040513-103718","article-title":"Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo","volume":"66","author":"Lane","year":"2015","journal-title":"Annu. Rev. Phys. Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40005-018-0399-z","article-title":"Nano delivery systems and cancer immunotherapy","volume":"48","author":"Le","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"B99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajps.2018.07.003","article-title":"Nanomaterials for modulating innate immune cells in cancer immunotherapy","volume":"14","author":"Le","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.carbpol.2013.02.018","article-title":"Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment","volume":"94","author":"Lee","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"B102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s40820-019-0266-0","article-title":"Crushed gold shell nanoparticles labeled with radioactive iodine as a theranostic nanoplatform for macrophage-mediated photothermal therapy","volume":"11","author":"Lee","year":"2019","journal-title":"Nano-Micro Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"Lee","year":"2011","journal-title":"Cancers"},{"key":"B104","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cancers12020437","article-title":"FDA and EMA approvals of new breast cancer drugs\u2014a comparative regulatory analysis","volume":"12","author":"Leo","year":"2020","journal-title":"Cancers"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e1807211","DOI":"10.1002\/adma.201807211","article-title":"Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation","volume":"31","author":"Li","year":"2019","journal-title":"Adv. Math."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post- phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/rb\/rbw044","article-title":"Self-assembled PEG-b-PDPA-b-PGEM copolymer nanoparticles as protein antigen delivery vehicles to dendritic cells: preparation, characterization and cellular uptake","volume":"4","author":"Li","year":"2017","journal-title":"Regen. Biomater."},{"key":"B108","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fphar.2017.00855","article-title":"Drugs and targets in fibrosis","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B."},{"key":"B110","doi-asserted-by":"publisher","first-page":"16738","DOI":"10.1039\/c8nr05803b","article-title":"EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer","volume":"10","author":"Li","year":"2018","journal-title":"Nanoscale"},{"key":"B111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jconrel.2016.01.044","article-title":"Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation","volume":"231","author":"Li","year":"2016","journal-title":"J. Contr. Release"},{"key":"B112","doi-asserted-by":"publisher","first-page":"111097","DOI":"10.1016\/j.msec.2020.111097","article-title":"Biomimetic theranostic strategy for anti-metastasis therapy of breast cancer via the macrophage membrane camouflaged superparticles","volume":"115","author":"Liang","year":"2020","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1039\/c3tb20455c","article-title":"Self-assembled inorganic\/organic hybrid nanoparticles with multi-functionalized surfaces for active targeting drug delivery","volume":"1","author":"Liang","year":"2013","journal-title":"J. Mater. Chem. B."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/ijc.27784","article-title":"Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer","volume":"132","author":"Lin","year":"2013","journal-title":"Int. J. Canc."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1021\/ja4108287","article-title":"Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors","volume":"136","author":"Ling","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B116","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nano.2008.01.001","article-title":"Nanotoxicology and nanomedicine: making hard decisions","volume":"4","author":"Linkov","year":"2008","journal-title":"Nanomedicine: NBM (NMR Biomed.)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/smll.201503662","article-title":"Pathogen-mimicking polymeric nanoparticles based on dopamine polymerization as vaccines adjuvants induce robust humoral and cellular immune responses","volume":"12","author":"Liu","year":"2016","journal-title":"Small"},{"key":"B118","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-associated fibroblasts build and secure the tumor microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"8811","DOI":"10.1021\/acsnano.9b01979","article-title":"Ferrimagnetic vortex nanoring-mediated mild magnetic hyperthermia imparts potent immunological effect for treating cancer metastasis","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"B120","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s40820-019-0330-9","article-title":"Cell membrane coating technology: a promising strategy for biomedical applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nano-Micro Lett."},{"key":"B121","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/medsci6040100","article-title":"Theranostics applications of nanoparticles in cancer immunotherapy","volume":"6","author":"Liu","year":"2018","journal-title":"Med. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"key":"B123","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1021\/jacs.6b06663","article-title":"Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy","volume":"138","author":"Lu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"B124","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/mt.2015.165","article-title":"Curcumin micelles remodel tumor microenvironment and enhance vaccine activity in an advanced melanoma model","volume":"24","author":"Lu","year":"2016","journal-title":"Mol. Ther."},{"key":"B125","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","article-title":"A STING-activating nanovaccine for cancer immunotherapy","volume":"12","author":"Luo","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01264","article-title":"Recent trends of the bio-inspired nanoparticles in cancer theranostics","volume":"10","author":"Madamsetty","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"23786","DOI":"10.1074\/jbc.M114.551879","article-title":"Interferon-\u03b1 acts on the S\/G2\/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line","volume":"289","author":"Maeda","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1039\/d0na00286k","article-title":"Role of inorganic nanoparticle degradation in cancer therapy","volume":"2","author":"Maksoudian","year":"2020","journal-title":"Nanoscale Adv."},{"key":"B129","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ijbiomac.2016.06.007","article-title":"Doxorubicin-loaded fucoidan capped gold nanoparticles for drug delivery and photoacoustic imaging","volume":"91","author":"Manivasagan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1021\/nn403158n","article-title":"Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy","volume":"7","author":"Marrache","year":"2013","journal-title":"ACS Nano"},{"key":"B132","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15171\/bi.2014.008","article-title":"Impacts of quantum dots in molecular detection and bioimaging of cancer","volume":"4","author":"Mashinchian","year":"2014","journal-title":"Bioimpacts"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1158\/1078-0432.CCR-18-2108","article-title":"A phase I\/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent head and neck squamous cell carcinoma","volume":"25","author":"Mcmichael","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017016983","article-title":"Applications and risks of nanomaterials used in regenerative medicine, delivery systems, theranostics, and therapy","volume":"34","author":"Medina-Reyes","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"B135","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1021\/acsnano.5b01939","article-title":"Nanomedicine for cancer immunotherapy\u202f: tracking cancer- specific T-cells in vivo with gold nanoparticles and CT imaging","volume":"9","author":"Meir","year":"2015","journal-title":"ACS Nano"},{"key":"B136","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc3973","article-title":"Evolving synergistic combinations of targeted immunotherapies to combat cancer","volume":"15","author":"Melero","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"B137","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-813339-2.00009-8","article-title":"Targeted nanotheranostics for selective drug delivery in cancer","volume-title":"The handbook of nanomaterials for cancer theranostics","author":"Mendes","year":"2018"},{"key":"B138","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"key":"B139","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.leu.2403217","article-title":"Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study","volume":"18","author":"Michallet","year":"2004","journal-title":"Leukemia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","article-title":"Cancer statistics for adolescents and young adults","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"B141","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1038\/ncomms9692","article-title":"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug","volume":"6","author":"Miller","year":"2015","journal-title":"Nat. Commun."},{"key":"B142","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1385\/IR:29:1-3:197","article-title":"Anti-CD137 antibodies in the treatment of autoimmune disease and cancer","volume":"29","author":"Mittler","year":"2004","journal-title":"Immunol. Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat. Commun."},{"key":"B144","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.biomaterials.2011.11.063","article-title":"Activation of inflammasomes by tumor cell death mediated by gold nanoshells","volume":"33","author":"Nguyen","year":"2012","journal-title":"Biomaterials"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-8140(93)90179-C","article-title":"Beneficial liaisons: radiobiology meets cellular and molecular biology","volume":"28","author":"Norman Coleman","year":"1993","journal-title":"Radiother. Oncol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1021\/acs.biomac.7b00158","article-title":"Protein corona formation on colloidal polymeric nanoparticles and polymeric nanogels: impact on cellular uptake, toxicity, immunogenicity, and drug release properties","volume":"18","author":"Obst","year":"2017","journal-title":"Biomacromolecules"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.7150\/thno.26758","article-title":"Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy","volume":"8","author":"Ou","year":"2018","journal-title":"Theranostics"},{"key":"B149","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"key":"B150","doi-asserted-by":"publisher","first-page":"212","DOI":"10.6004\/jadpro.2015.6.3.3","article-title":"The toxicity and benefit of various dosing strategies for interleukin-2 in metastatic melanoma and renal cell carcinoma","volume":"6","author":"Pachella","year":"2015","journal-title":"J. Adv. Pract. Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nmat3355","article-title":"Combination delivery of TGF-\u03b2 inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy","volume":"11","author":"Park","year":"2012","journal-title":"Nat. Mater."},{"key":"B153","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomater. Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.26013","article-title":"Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer","volume":"57","author":"Pedroza-Gonzalez","year":"2013","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy\u202f: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fbioe.2019.00197","article-title":"Nanotheranostics targeting the tumor microenvironment","volume":"7","author":"Roma-Rodrigues","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"B160","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1667\/RR13495.1","article-title":"Radiation as Immunomodulator\u202f: implications for dendritic cell-based immunotherapy","volume":"182","author":"Roses","year":"2014","journal-title":"Radiat. Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/bc400070q","article-title":"In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes","volume":"24","author":"Sacchetti","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"B162","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1158\/1535-7163.MCT-13-0633","article-title":"The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy","volume":"13","author":"Sano","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"B164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biomaterials.2016.04.010","article-title":"Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy","volume":"96","author":"Sasso","year":"2016","journal-title":"Biomaterials"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/eji.201142347","article-title":"Phenotypic and functional characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients","volume":"42","author":"Schuler","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/mi.2013.62","article-title":"Highly prevalent colorectal cancer-infiltrating LAP + Foxp3 - T cells exhibit more potent immunosuppressive activity than Foxp3 + regulatory T cells","volume":"7","author":"Scurr","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature03794","article-title":"Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system","volume":"436","author":"Sengupta","year":"2005","journal-title":"Nature"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s12274-014-0635-4","article-title":"A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors","volume":"8","author":"Shahbazi","year":"2015","journal-title":"Nano Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/nnm.15.186","article-title":"Antibody-targeted biodegradable nanoparticles for cancer therapy","volume":"11","author":"Shargh","year":"2016","journal-title":"Nanomedicine"},{"key":"B170","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4155\/tde-2018-0076","article-title":"Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto","volume":"10","author":"Shetab Boushehri","year":"2019","journal-title":"Ther. Deliv."},{"key":"B171","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1039\/c4nr01927j","article-title":"Au@Ag\/Au nanoparticles assembled with activatable aptamer probes as smart \u201cnano-doctors\u201d for image-guided cancer thermotherapy","volume":"6","author":"Shi","year":"2014","journal-title":"Nanoscale"},{"key":"B172","doi-asserted-by":"publisher","first-page":"9709","DOI":"10.1016\/j.biomaterials.2013.08.064","article-title":"Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(\u03b3-glutamic acid) nanoparticles","volume":"34","author":"Shima","year":"2013","journal-title":"Biomaterials"},{"key":"B173","doi-asserted-by":"publisher","first-page":"26332","DOI":"10.1038\/srep26332","article-title":"Cross-linked composite gel polymer electrolyte using mesoporous methacrylate-functionalized SiO2 nanoparticles for lithium-ion polymer batteries","volume":"6","author":"Shin","year":"2016","journal-title":"Sci. Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/smll.201201470","article-title":"Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells","volume":"9","author":"Shvedova","year":"2013","journal-title":"Small"},{"key":"B175","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"B176","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jocit.2016.08.002","article-title":"Nanomedicine targeting the tumor microenvironment: therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses","volume":"2","author":"Siegler","year":"2016","journal-title":"J. Cell. Immunother."},{"key":"B177","doi-asserted-by":"publisher","first-page":"10301","DOI":"10.1021\/acsnano.9b03727","article-title":"Biomimetic magnetic nanostructures: a theranostic platform targeting lipid metabolism and immune response in lymphoma","volume":"13","author":"Singh","year":"2019","journal-title":"ACS Nano"},{"key":"B178","doi-asserted-by":"publisher","first-page":"116130","DOI":"10.1016\/j.carbpol.2020.116130","article-title":"One-pot preparation of hyaluronic acid\u2010coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells","volume":"237","author":"Soleymani","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"B179","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biomaterials.2017.09.017","article-title":"Nanomaterials for cancer immunotherapy","volume":"148","author":"Song","year":"2017","journal-title":"Biomaterials"},{"key":"B180","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41467-018-04605-x","article-title":"Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap","volume":"9","author":"Song","year":"2018","journal-title":"Nat. Commun."},{"key":"B181","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-Type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B182","doi-asserted-by":"publisher","first-page":"119342","DOI":"10.1016\/j.biomaterials.2019.119342","article-title":"Intranasal delivery of targeted polyfunctional gold\u2013iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide","volume":"218","author":"Sukumar","year":"2019","journal-title":"Biomaterials"},{"key":"B183","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"B184","doi-asserted-by":"publisher","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"key":"B185","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd.2018.210","article-title":"The clinical trial landscape for PD1\/PDl1 immune checkpoint inhibitors","volume":"17","author":"Tang","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B186","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1016\/j.biomaterials.2014.04.073","article-title":"Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy","volume":"35","author":"Tao","year":"","journal-title":"Biomaterials"},{"key":"B187","doi-asserted-by":"publisher","first-page":"9963","DOI":"10.1016\/j.biomaterials.2014.08.036","article-title":"Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal\/immune cancer therapy","volume":"35","author":"Tao","year":"","journal-title":"Biomaterials"},{"key":"B188","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1021\/acsbiomaterials.8b01173","article-title":"Progress in remotely triggered hybrid nanostructures for next-generation brain cancer theranostics","volume":"5","author":"Thorat","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B189","doi-asserted-by":"publisher","first-page":"11541","DOI":"10.1021\/acsnano.8b06699","article-title":"Calcium bisphosphonate nanoparticles with chelator-free radiolabeling to deplete tumor-associated macrophages for enhanced cancer radioisotope therapy","volume":"12","author":"Tian","year":"2018","journal-title":"ACS Nano"},{"key":"B190","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2018.03.029","article-title":"Nanoparticles for dendritic cell-based immunotherapy","volume":"542","author":"Tran","year":"2018","journal-title":"Int. J. Pharm."},{"key":"B191","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"B192","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/polym6010179","article-title":"Polyester dendrimers: smart carriers for drug delivery","volume":"6","author":"Twibanire","year":"2014","journal-title":"Polymers"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.3390\/ijms12063888","article-title":"Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications","volume":"12","author":"Vivero-Escoto","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"B195","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1021\/acs.nanolett.6b01994","article-title":"Acid-activatable versatile micelleplexes for PD-l1 blockade-enhanced cancer photodynamic immunotherapy","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."},{"key":"B198","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","article-title":"Biomaterial-assisted targeted modulation of immune cells in cancer treatment","volume":"17","author":"Wang","year":"2018","journal-title":"Nat. Mater."},{"key":"B199","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40169-016-0091-8","article-title":"Cancer Moonshot 2020: a new march of clinical and translational medicine","volume":"5","author":"Wang","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1039\/c5tb00956a","article-title":"An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy","volume":"3","author":"Wang","year":"2015","journal-title":"J. Mater. Chem. B."},{"key":"B201","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","article-title":"Polymeric nanoparticles enable reversing macrophage in tumor microenvironment for immunotherapy","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1900582","DOI":"10.1002\/advs.201900582","article-title":"Targeted delivery of siRNA lipoplexes to cancer cells using macrophage transient horizontal gene transfer","volume":"6","author":"Wayne","year":"2019","journal-title":"Adv. Sci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/adhm.201600923","article-title":"Dendrimer-stabilized gold nanostars as a multifunctional theranostic nanoplatform for CT imaging, photothermal therapy, and gene silencing of tumors","volume":"5","author":"Wei","year":"2016","journal-title":"Adv. Healthc. Mater"},{"key":"B204","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0305-7372(89)90027-3","article-title":"Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies","volume":"16","author":"West","year":"1989","journal-title":"Canc. Treat Rev."},{"key":"B205","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1002\/anie.201404766","article-title":"Development of multinuclear polymeric nanoparticles as robust protein nanocarriers","volume":"53","author":"Wu","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1039\/c7qm00153c","article-title":"Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications","volume":"1","author":"Xu","year":"2017","journal-title":"Mater. Chem. Front."},{"key":"B207","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fimmu.2015.00408","article-title":"Targeting C-type lectin receptors for cancer immunity","volume":"6","author":"Yan","year":"2015","journal-title":"Front. Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","article-title":"Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination","volume":"12","author":"Yang","year":"2018","journal-title":"ACS Nano"},{"key":"B209","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s11671-016-1468-8","article-title":"Human CIK cells loaded with Au nanorods as a theranostic platform for targeted photoacoustic imaging and enhanced immunotherapy and photothermal therapy","volume":"11","author":"Yang","year":"2016","journal-title":"Nanoscale Res. Lett."},{"key":"B223","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.biomaterials.2019.01.026","article-title":"Multifunctional nanoplatform for photoacoustic imaging-guided combined therapy enhanced by CO induced ferroptosis","volume":"197","author":"Yao","year":"2019","journal-title":"Biomaterials"},{"key":"B210","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.21873\/anticanres.11777","article-title":"Clinical study on the medical value of combination therapy involving adoptive immunotherapy and chemotherapy for stage IV colorectal cancer (COMVI Study)","volume":"37","author":"Yoshida","year":"2017","journal-title":"Anticancer Res."},{"key":"B211","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40425-016-0107-3","article-title":"Novel technologies and emerging biomarkers for personalized cancer immunotherapy","volume":"4","author":"Yuan","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41467-019-09760-3","article-title":"Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice","volume":"10","author":"Yue","year":"2019","journal-title":"Nat. Commun."},{"key":"B213","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/2472630317738699","article-title":"Theranostic nanoparticles for tracking and monitoring disease state","volume":"23","author":"Zavaleta","year":"2018","journal-title":"SLAS Technol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1021\/acsnano.9b00892","article-title":"Engineering magnetosomes for ferroptosis\/immunomodulation synergism in cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"B215","doi-asserted-by":"publisher","first-page":"30502","DOI":"10.1021\/acsami.7b10086","article-title":"Bioinspired \u201cactive\u201d stealth magneto-nanomicelles for theranostics combining efficient MRI and enhanced drug delivery","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1701027","DOI":"10.1002\/adfm.201701027","article-title":"Multifunctional molecular beacon micelles for intracellular mRNA imaging and synergistic therapy in multidrug-resistant cancer cells","volume":"27","author":"Zhang","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"B217","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.05.015","article-title":"Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy","volume":"174","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"B218","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1021\/acs.nanolett.8b03096","article-title":"Unique photochemo-immuno-nanoplatform against orthotopic xenograft oral cancer and metastatic syngeneic breast cancer","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"B219","doi-asserted-by":"publisher","first-page":"e1707112","DOI":"10.1002\/adma.201707112","article-title":"PD-1 blockade cellular vesicles for cancer immunotherapy","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"B220","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s11671-018-2661-8","article-title":"Modified Fe3O4 magnetic nanoparticle delivery of CpG inhibits tumor growth and spontaneous pulmonary metastases to enhance immunotherapy","volume":"13","author":"Zhang","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"B221","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-017-02251-3","article-title":"Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"B222","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1073\/pnas.1220817110","article-title":"Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2020.631351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T21:20:14Z","timestamp":1670966414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2020.631351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":223,"alternative-id":["10.3389\/fchem.2020.631351"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2020.631351","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"article-number":"631351"}}